Barry Heather E, Cooper Janine A, Ryan Cristín, Passmore A Peter, Robinson A Louise, Molloy Gerard J, Darcy Carmel M, Buchanan Hilary, Hughes Carmel M
School of Pharmacy, Queen's University Belfast, Belfast, UK.
School of Pharmacy, Royal College of Surgeons in Ireland, Dublin, Ireland.
J Alzheimers Dis. 2016 Apr 11;52(4):1503-13. doi: 10.3233/JAD-151177.
Little is known about prescribing appropriateness for community-dwelling people with dementia (PWD).
To estimate potentially inappropriate prescribing (PIP) prevalence among PWD in primary care in Northern Ireland, and to investigate associations between PIP, polypharmacy, age, and gender.
A retrospective cross-sectional study was conducted, using data from the Enhanced Prescribing Database. Patients were eligible if a medicine indicated for dementia management was dispensed to them during 1 January 2013-31 December 2013. Polypharmacy was indicated by use of ≥4 repeat medications from different drug groups. A subset of the Screening Tool of Older Persons Potentially Inappropriate Prescriptions (STOPP) criteria, comprising 36 indicators, was applied to the dataset. Overall prevalence of PIP and the prevalence per each STOPP criterion was calculated as a proportion of all eligible persons in the dataset. Logistic regression was used to investigate associations between PIP, polypharmacy, age, and gender.
The study population comprised 6826 patients. Polypharmacy was observed in 81.5% (n = 5564) of patients. PIP prevalence during the study period was 64.4% (95% CI 63.2- 65.5; n = 4393). The most common instance of PIP was the use of anticholinergic/antimuscarinic medications (25.2%; 95% CI 24.2-26.2; n = 1718). In multivariable analyses, both polypharmacy and gender (being female) were associated with PIP, with odds ratios of 7.6 (95% CI 6.6-8.7) and 1.3 (95% CI 1.2-1.4), respectively. No association was observed between PIP and age, after adjustments for gender and polypharmacy.
This study identified a high prevalence of PIP in community-dwelling PWD. Future interventions may need to focus on certain therapeutic categories and polypharmacy.
对于社区居住的痴呆症患者(PWD)的处方适宜性了解甚少。
估计北爱尔兰初级保健中PWD的潜在不适当处方(PIP)患病率,并调查PIP、多重用药、年龄和性别之间的关联。
进行了一项回顾性横断面研究,使用增强处方数据库的数据。如果在2013年1月1日至2013年12月31日期间为患者配药了用于痴呆症管理的药物,则该患者符合条件。使用来自不同药物组的≥4种重复用药表明存在多重用药。将老年人潜在不适当处方筛查工具(STOPP)标准的一个子集(包括36项指标)应用于数据集。PIP的总体患病率以及每个STOPP标准的患病率以数据集中所有符合条件的人的比例计算。使用逻辑回归来研究PIP、多重用药、年龄和性别之间的关联。
研究人群包括6826名患者。81.5%(n = 5564)的患者存在多重用药。研究期间PIP患病率为64.4%(95%CI 63.2 - 65.5;n = 4393)。PIP最常见的情况是使用抗胆碱能/抗毒蕈碱药物(25.2%;95%CI 24.2 - 26.2;n = 1718)。在多变量分析中,多重用药和性别(女性)均与PIP相关,比值比分别为7.6(95%CI 6.6 - 8.7)和1.3(95%CI 1.2 - 1.4)。在对性别和多重用药进行调整后,未观察到PIP与年龄之间存在关联。
本研究发现社区居住的PWD中PIP患病率很高。未来的干预措施可能需要关注某些治疗类别和多重用药。